HO-1/CO system in tumor growth, angiogenesis and metabolism — Targeting HO-1 as an anti-tumor therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Folkman, 1971, Tumor angiogenesis: therapeutic implications, N. Engl. J. Med., 285, 1182, 10.1056/NEJM197111182852108
Tenhunen, 1968, The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase, Proc. Natl. Acad. Sci. U. S. A., 61, 748, 10.1073/pnas.61.2.748
Loboda, 2008, Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities, Antioxid. Redox Signal., 10, 1767, 10.1089/ars.2008.2043
Stocker, 1987, Antioxidant activity of albumin-bound bilirubin, Proc. Natl. Acad. Sci. U. S. A., 84, 5918, 10.1073/pnas.84.16.5918
Stocker, 1990, Antioxidant activities of bile pigments: biliverdin and bilirubin, Methods Enzymol., 186, 301, 10.1016/0076-6879(90)86123-D
Stocker, 1987, Bilirubin is an antioxidant of possible physiological importance, Science, 235, 1043, 10.1126/science.3029864
Wegiel, B., et al., Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J. Biol. Chem., 2009. 284(32): p. 21369–21378.
Gibbs, 2012, Biliverdin reductase: more than a namesake — the reductase, its peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C, Front. Pharmacol., 3, 31, 10.3389/fphar.2012.00031
Pae, 2010, Role of heme oxygenase in preserving vascular bioactive NO, Nitric Oxide, 23, 251, 10.1016/j.niox.2010.08.002
Tanaka, 2003, Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour, Br. J. Cancer, 88, 902, 10.1038/sj.bjc.6600830
Busserolles, 2006, Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway, Int. J. Biochem. Cell Biol., 38, 1510, 10.1016/j.biocel.2006.03.013
Ollinger, 2007, Bilirubin inhibits tumor cell growth via activation of ERK, Cell Cycle, 6, 3078, 10.4161/cc.6.24.5022
Zheng, 2014, Biliverdin's regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer, Br. J. Cancer, 110, 2116, 10.1038/bjc.2014.98
Ikeda, 2015, Bilirubin exerts pro-angiogenic property through Akt–eNOS-dependent pathway, Hypertens. Res., 10.1038/hr.2015.74
Hayashi, 1999, Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme, Circ. Res., 85, 663, 10.1161/01.RES.85.8.663
Wen, 2015, The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling, Clin. Cancer Res., 21, 193, 10.1158/1078-0432.CCR-14-0748
Ching, 2002, Serum levels of micronutrients, antioxidants and total antioxidant status predict risk of breast cancer in a case control study, J. Nutr., 132, 303, 10.1093/jn/132.2.303
Zucker, 2004, Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer, Hepatology, 40, 827, 10.1002/hep.1840400412
Li, 2015, Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer, Cancer Epidemiol., 39, 763, 10.1016/j.canep.2015.06.007
Eisenstein, 1991, Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron, Proc. Natl. Acad. Sci. U. S. A., 88, 688, 10.1073/pnas.88.3.688
Baranano, 2000, A mammalian iron ATPase induced by iron, J. Biol. Chem., 275, 15166, 10.1074/jbc.275.20.15166
Coffman, 2009, Regulatory effects of ferritin on angiogenesis, Proc. Natl. Acad. Sci. U. S. A., 106, 570, 10.1073/pnas.0812010106
Tesfay, 2012, Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells, PLoS One, 7, 10.1371/journal.pone.0040030
Lui, 2015, Targeting cancer by binding iron: dissecting cellular signaling pathways, Oncotarget, 6, 18748, 10.18632/oncotarget.4349
Lane, 2014, Expanding horizons in iron chelation and the treatment of cancer: role of iron in the regulation of ER stress and the epithelial–mesenchymal transition, Biochim. Biophys. Acta, 1845, 166
Gozzelino, 2010, Mechanisms of cell protection by heme oxygenase-1, Annu. Rev. Pharmacol. Toxicol., 50, 323, 10.1146/annurev.pharmtox.010909.105600
Deng, 2013, Inhibition of tumor growth and alteration of associated macrophage cell type by an HO-1 inhibitor in breast carcinoma-bearing mice, Oncol. Res., 20, 473, 10.3727/096504013X13715991125684
Sierra-Filardi, 2010, Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release, Immunobiology, 215, 788, 10.1016/j.imbio.2010.05.020
Dulak, 2008, Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis, Circulation, 117, 231, 10.1161/CIRCULATIONAHA.107.698316
Yamamoto, 2014, Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway, Nat. Commun., 5, 3480, 10.1038/ncomms4480
Kozakowska, 2014, Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs, Antioxid. Redox Signal., 20, 1827, 10.1089/ars.2013.5341
Was, 2010, Heme oxygenase-1 in tumor biology and therapy, Curr. Drug Targets, 11, 1551, 10.2174/1389450111009011551
Was, 2011, Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice, Free Radic. Biol. Med., 51, 1717, 10.1016/j.freeradbiomed.2011.07.025
Kozakowska, 2012, Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs, Antioxid. Redox Signal., 16, 113, 10.1089/ars.2011.3964
Ciesla, 2014, MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development, Int. J. Biochem. Cell Biol., 53, 482, 10.1016/j.biocel.2014.05.003
Marinissen, 2006, Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor, J. Biol. Chem., 281, 11332, 10.1074/jbc.M512199200
Martin, 2007, The Galpha12/13 family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis, J. Biol. Chem., 282, 34510, 10.1074/jbc.M703043200
Mayerhofer, 2004, Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia, Cancer Res., 64, 3148, 10.1158/0008-5472.CAN-03-1200
Singh, 2012, Inhibition of the NADPH oxidase regulates heme oxygenase 1 expression in chronic myeloid leukemia, Cancer, 118, 3433, 10.1002/cncr.26621
Yoshida, 2007, Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1, Blood, 109, 1211, 10.1182/blood-2005-12-040972
Cerny-Reiterer, 2014, Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia, Oncotarget, 5, 1198, 10.18632/oncotarget.1805
Kondo, 2007, Identification of heat shock protein 32 (Hsp32) as a novel survival factor and therapeutic target in neoplastic mast cells, Blood, 110, 661, 10.1182/blood-2006-10-054411
Banerjee, 2013, The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways, Cancer Lett., 338, 292, 10.1016/j.canlet.2013.05.036
McAllister, 2004, Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells, Blood, 103, 3465, 10.1182/blood-2003-08-2781
Birrane, 2013, Cigarette smoke induces nuclear translocation of heme oxygenase 1 (HO-1) in prostate cancer cells: nuclear HO-1 promotes vascular endothelial growth factor secretion, Int. J. Oncol., 42, 1919, 10.3892/ijo.2013.1910
Was, 2006, Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice, Am. J. Pathol., 169, 2181, 10.2353/ajpath.2006.051365
Sunamura, 2003, Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer, Angiogenesis, 6, 15, 10.1023/A:1025803600840
Nishie, 1999, Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas, Clin. Cancer Res., 5, 1107
Hirai, 2007, Inhibition of heme oxygenase-1 by zinc protoporphyrin IX reduces tumor growth of LL/2 lung cancer in C57BL mice, Int. J. Cancer, 120, 500, 10.1002/ijc.22287
Loboda, 2015, Carbonmonoxide: pro- or anti-angiogenic agent? Comment on Ahmad et al. (Thromb Haemost 2015; 113: 329–337), Thromb. Haemost., 114
Chan, 2011, Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential, Clin. Sci. (Lond.), 120, 493, 10.1042/CS20100508
Deshane, 2007, Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism, J. Exp. Med., 204, 605, 10.1084/jem.20061609
Choi, 2010, Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein, J. Biol. Chem., 285, 32116, 10.1074/jbc.M110.131284
Chin, 2007, Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning, Proc. Natl. Acad. Sci. U. S. A., 104, 5109, 10.1073/pnas.0609611104
Sengupta, 2003, Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms, Br. J. Pharmacol., 139, 219, 10.1038/sj.bjp.0705216
Tertil, 2014, Regulation and novel action of thymidine phosphorylase in non-small cell lung cancer: crosstalk with Nrf2 and HO-1, PLoS One, 9, 10.1371/journal.pone.0097070
Skrzypek, 2013, Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis, Antioxid. Redox Signal., 19, 644, 10.1089/ars.2013.5184
Gueron, 2009, Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells, Mol. Cancer Res., 7, 1745, 10.1158/1541-7786.MCR-08-0325
Vitek, 2014, Antiproliferative effects of carbon monoxide on pancreatic cancer, Dig. Liver Dis., 46, 369, 10.1016/j.dld.2013.12.007
Ahmad, 2015, Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation, Thromb. Haemost., 113, 329, 10.1160/TH14-01-0002
Wegiel, 2013, The social network of carbon monoxide in medicine, Trends Mol. Med., 19, 3, 10.1016/j.molmed.2012.10.001
Arnold, 2014, Tumoral immune suppression by macrophages expressing fibroblast activation protein-alpha and heme oxygenase-1, Cancer Immunol. Res., 2, 121, 10.1158/2326-6066.CIR-13-0150
Andersen, 2009, Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients, J. Clin. Invest., 119, 2245, 10.1172/JCI38739
El Andaloussi, 2007, CD4+ CD25+ FoxP3+ T-cell infiltration and heme oxygenase-1 expression correlate with tumor grade in human gliomas, J. Neuro-Oncol., 83, 145, 10.1007/s11060-006-9314-y
Dey, 2014, Heme oxygenase-1 protects regulatory T cells from hypoxia-induced cellular stress in an experimental mouse brain tumor model, J. Neuroimmunol., 266, 33, 10.1016/j.jneuroim.2013.10.012
Hull, 2014, The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1, Antioxid. Redox Signal., 20, 1770, 10.1089/ars.2013.5673
Riganti, 2012, The pentose phosphate pathway: an antioxidant defense and a crossroad in tumor cell fate, Free Radic. Biol. Med., 53, 421, 10.1016/j.freeradbiomed.2012.05.006
Hishiki, 2012, Carbon monoxide: impact on remethylation/transsulfuration metabolism and its pathophysiologic implications, J. Mol. Med. (Berl.), 90, 245, 10.1007/s00109-012-0875-2
De Bock, 2013, Role of PFKFB3-driven glycolysis in vessel sprouting, Cell, 154, 651, 10.1016/j.cell.2013.06.037
Ghesquiere, 2014, Metabolism of stromal and immune cells in health and disease, Nature, 511, 167, 10.1038/nature13312
Faller, 2007, Heme is involved in microRNA processing, Nat. Struct. Mol. Biol., 14, 23, 10.1038/nsmb1182
Weitz, 2014, Processing of microRNA primary transcripts requires heme in mammalian cells, Proc. Natl. Acad. Sci. U. S. A., 111, 1861, 10.1073/pnas.1309915111
Hua, 2006, MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia, PLoS One, 1, 10.1371/journal.pone.0000116
Wang, 2009, AngiomiRs—key regulators of angiogenesis, Curr. Opin. Genet. Dev., 19, 205, 10.1016/j.gde.2009.04.002
Banerjee, 2011, The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras–Raf–ERK pathway and mediates anti-apoptotic signal, J. Biol. Chem., 286, 33580, 10.1074/jbc.M111.248401
Banerjee, 2012, Heme oxygenase-1 promotes survival of renal cancer cells through modulation of apoptosis- and autophagy-regulating molecules, J. Biol. Chem., 287, 32113, 10.1074/jbc.M112.393140
Kim, 2004, Caveolae compartmentalization of heme oxygenase-1 in endothelial cells, FASEB J., 18, 1080, 10.1096/fj.03-1391com
Maines, 1997, The heme oxygenase system: a regulator of second messenger gases, Annu. Rev. Pharmacol. Toxicol., 37, 517, 10.1146/annurev.pharmtox.37.1.517
Sacca, 2007, Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer, Br. J. Cancer, 97, 1683, 10.1038/sj.bjc.6604081
Lin, 2007, Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress, J. Biol. Chem., 282, 20621, 10.1074/jbc.M607954200
Dunn, 2014, New insights into intracellular locations and functions of heme oxygenase-1, Antioxid. Redox Signal., 20, 1723, 10.1089/ars.2013.5675
Hori, 2002, Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity, J. Biol. Chem., 277, 10712, 10.1074/jbc.M107749200
Biswas, 2014, Nuclear heme oxygenase-1 (HO-1) modulates subcellular distribution and activation of Nrf2, impacting metabolic and anti-oxidant defenses, J. Biol. Chem., 289, 26882, 10.1074/jbc.M114.567685
Dennery, 2014, Signaling function of heme oxygenase proteins, Antioxid. Redox Signal., 20, 1743, 10.1089/ars.2013.5674
Wegiel, 2013, Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth, Cancer Res., 73, 7009, 10.1158/0008-5472.CAN-13-1075
Li, 2008, Haem oxygenase-1 plays a central role in NNK-mediated lung carcinogenesis, Eur. Respir. J., 32, 911, 10.1183/09031936.00064508
Degese, 2012, Expression of heme oxygenase-1 in non-small cell lung cancer (NSCLC) and its correlation with clinical data, Lung Cancer, 77, 168, 10.1016/j.lungcan.2012.02.016
Gandini, 2012, Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas, Exp. Mol. Pathol., 93, 237, 10.1016/j.yexmp.2012.05.001
Hsu, 2015, Signal peptide peptidase-mediated nuclear localization of heme oxygenase-1 promotes cancer cell proliferation and invasion independent of its enzymatic activity, Oncogene, 34, 2410, 10.1038/onc.2014.464
Hill, 2005, Heme oxygenase-1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2,3-dioxygenase, FASEB J., 19, 1957, 10.1096/fj.05-3875com
Lee, 2014, The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide, Toxicol. Appl. Pharmacol., 274, 55, 10.1016/j.taap.2013.10.027
Lin, 2008, Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9, Mol. Cancer Ther., 7, 1195, 10.1158/1535-7163.MCT-07-2199
Kim, 2009, 15-Deoxy-Delta12,14-prostaglandin J2 upregulates the expression of heme oxygenase-1 and subsequently matrix metalloproteinase-1 in human breast cancer cells: possible roles of iron and ROS, Carcinogenesis, 30, 645, 10.1093/carcin/bgp012
Nielsen, 2013, Plasmatic hypercoagulation in patients with breast cancer: role of heme oxygenase-1, Blood Coagul. Fibrinolysis, 24, 809, 10.1097/MBC.0b013e3283658b00
Nielsen, 2014, Carbon monoxide: anticoagulant or procoagulant?, Thromb. Res., 133, 315, 10.1016/j.thromres.2013.12.004
Tsai, 2012, High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients, Cell. Oncol. (Dordr.), 35, 461, 10.1007/s13402-012-0105-5
Kim, 2008, Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin, Lung Cancer, 60, 47, 10.1016/j.lungcan.2007.09.021
Kuroda, 2010, Inhibition of heme oxygenase-1 with an epidermal growth factor receptor inhibitor and cisplatin decreases proliferation of lung cancer A549 cells, Lung Cancer, 67, 31, 10.1016/j.lungcan.2009.03.015
Lee, 1996, Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia, Proc. Natl. Acad. Sci. U. S. A., 93, 10393, 10.1073/pnas.93.19.10393
Homma, 2009, Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer, Clin. Cancer Res., 15, 3423, 10.1158/1078-0432.CCR-08-2822
Nuhn, 2009, Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo, Mol. Cancer, 8, 37, 10.1186/1476-4598-8-37
Berberat, 2005, Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment, Clin. Cancer Res., 11, 3790, 10.1158/1078-0432.CCR-04-2159
Maines, 1996, Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution, Urology, 47, 727, 10.1016/S0090-4295(96)00010-6
Alaoui-Jamali, 2009, A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer, Cancer Res., 69, 8017, 10.1158/0008-5472.CAN-09-0419
Li, 2011, PTEN deletion and heme oxygenase-1 overexpression cooperate in prostate cancer progression and are associated with adverse clinical outcome, J. Pathol., 224, 90, 10.1002/path.2855
Ferrando, 2011, Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer, Angiogenesis, 14, 467, 10.1007/s10456-011-9230-4
Elguero, 2012, Unveiling the association of STAT3 and HO-1 in prostate cancer: role beyond heme degradation, Neoplasia, 14, 1043, 10.1593/neo.121358
Ferrando, 2013, Heme oxygenase-1 (HO-1) expression in prostate cancer cells modulates the oxidative response in bone cells, PLoS One, 8, 10.1371/journal.pone.0080315
Gueron, 2014, Heme-oxygenase-1 implications in cell morphology and the adhesive behavior of prostate cancer cells, Oncotarget, 5, 4087, 10.18632/oncotarget.1826
Grundemar, 1997, Pitfalls using metalloporphyrins in carbon monoxide research, Trends Pharmacol. Sci., 18, 193, 10.1016/S0165-6147(97)01065-1
Fang, 2003, In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor, Cancer Res., 63, 3567
Metz, 2010, Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenase, Mol. Cancer Ther., 9, 1864, 10.1158/1535-7163.MCT-10-0185
La, 2009, Zinc protoporphyrin regulates cyclin D1 expression independent of heme oxygenase inhibition, J. Biol. Chem., 284, 36302, 10.1074/jbc.M109.031641
Wang, 2013, Zinc protoporphyrin suppresses cancer cell viability through a heme oxygenase-1-independent mechanism: the involvement of the Wnt/beta-catenin signaling pathway, Biochem. Pharmacol., 85, 1611, 10.1016/j.bcp.2013.03.011
Yang, 2001, Unique effects of zinc protoporphyrin on HO-1 induction and apoptosis, Blood, 97, 1306, 10.1182/blood.V97.5.1306
Sahoo, 2002, Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity, Bioconjug. Chem., 13, 1031, 10.1021/bc020010k
Fang, 2004, Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin, Int. J. Cancer, 109, 1, 10.1002/ijc.11644
Tsukigawa, 2015, Effect of different chemical bonds in pegylation of zinc protoporphyrin that affects drug release, intracellular uptake, and therapeutic effect in the tumor, Eur. J. Pharm. Biopharm., 89, 259, 10.1016/j.ejpb.2014.12.016
Fang, 2012, HSP32 (HO-1) inhibitor, copoly(styrene-maleic acid)-zinc protoporphyrin IX, a water-soluble micelle as anticancer agent: in vitro and in vivo anticancer effect, Eur. J. Pharm. Biopharm., 81, 540, 10.1016/j.ejpb.2012.04.016
Nakamura, 2011, Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles, J. Control. Release, 155, 367, 10.1016/j.jconrel.2011.04.025
Kinobe, 2008, Inhibitors of the heme oxygenase — carbon monoxide system: on the doorstep of the clinic?, Can. J. Physiol. Pharmacol., 86, 577, 10.1139/Y08-066
Salerno, 2015, Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines, Eur. J. Med. Chem., 96, 162, 10.1016/j.ejmech.2015.04.003
Salerno, 2013, Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties, Bioorg. Med. Chem., 21, 5145, 10.1016/j.bmc.2013.06.040
Frezza, 2011, Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase, Nature, 477, 225, 10.1038/nature10363
Linehan, 2013, Molecular pathways: fumarate hydratase-deficient kidney cancer—targeting the Warburg effect in cancer, Clin. Cancer Res., 19, 3345, 10.1158/1078-0432.CCR-13-0304
Isaacs, 2005, HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability, Cancer Cell, 8, 143, 10.1016/j.ccr.2005.06.017
Sudarshan, 2007, HIF and fumarate hydratase in renal cancer, Br. J. Cancer, 96, 403, 10.1038/sj.bjc.6603547
Nam, 2011, p53 promotes cellular survival in a context-dependent manner by directly inducing the expression of haeme-oxygenase-1, Oncogene, 30, 4476, 10.1038/onc.2011.150
Lin, 2013, TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation, Oncogene, 32, 2325, 10.1038/onc.2012.244
Mayerhofer, 2008, Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib, Blood, 111, 2200, 10.1182/blood-2006-11-055723
Tibullo, 2013, Nuclear translocation of heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells, Curr. Pharm. Des., 19, 2765, 10.2174/1381612811319150012
Lee, 2013, Proteomic strategy for probing complementary lethality of kinase inhibitors against pancreatic cancer, Proteomics, 13, 3554, 10.1002/pmic.201300248
Do, 2013, Metformin inhibits heme oxygenase-1 expression in cancer cells through inactivation of Raf–ERK–Nrf2 signaling and AMPK-independent pathways, Toxicol. Appl. Pharmacol., 271, 229, 10.1016/j.taap.2013.05.010
Chen, 2011, Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through redox regulation, J. Mol. Med. (Berl.), 89, 303, 10.1007/s00109-010-0707-1
Dulak, 2014, Novel faces of heme oxygenase-1: mechanisms and therapeutic potentials, Antioxid. Redox Signal., 20, 1673, 10.1089/ars.2013.5761
Otterbein, 2011, Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein, Proc. Natl. Acad. Sci. U. S. A., 108, 14491, 10.1073/pnas.1102295108
Zhang, 2013, Lung endothelial HO-1 targeting in vivo using lentiviral miRNA regulates apoptosis and autophagy during oxidant injury, FASEB J., 27, 4041, 10.1096/fj.13-231225
Yang, 2010, UOK 262 cell line, fumarate hydratase deficient (FH−/FH−) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer, Cancer Genet. Cytogenet., 196, 45, 10.1016/j.cancergencyto.2009.08.018
Wong, 2011, In vitro inhibition of heme oxygenase isoenzymes by metalloporphyrins, J. Perinatol., 31, S35, 10.1038/jp.2010.173
Gleixner, 2009, Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy, Curr. Cancer Drug Targets, 9, 675, 10.2174/156800909789057024
Rahman, 2013, Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds, J. R. Soc. Interface, 10, 20120697, 10.1098/rsif.2012.0697
Cuturi, 1999, RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action, Mol. Med., 5, 820, 10.1007/BF03401995
Sass, 2008, Inhibition of heme oxygenase 1 expression by small interfering RNA decreases orthotopic tumor growth in livers of mice, Int. J. Cancer, 123, 1269, 10.1002/ijc.23695